Long-term results of a randomized prospective study comparing medical and surgical treatment of Barrett's esophagus.

PubWeight™: 2.03‹?› | Rank: Top 2%

🔗 View Article (PMC 1514316)

Published in Ann Surg on March 01, 2003

Authors

Pascual Parrilla1, Luisa F Martínez de Haro, Angeles Ortiz, Vicente Munitiz, Joaquín Molina, Juan Bermejo, Manuel Canteras

Author Affiliations

1: Department of Surgery, University Hospital Virgen de la Arrixaca, El Palmar, Murcia, Spain. parricir@huva.es

Articles citing this

ACG Clinical Guideline: Diagnosis and Management of Barrett's Esophagus. Am J Gastroenterol (2015) 3.22

Guidelines for surgical treatment of gastroesophageal reflux disease. Surg Endosc (2010) 2.59

Comparing laparoscopic antireflux surgery with esomeprazole in the management of patients with chronic gastro-oesophageal reflux disease: a 3-year interim analysis of the LOTUS trial. Gut (2008) 1.93

Laparoscopic surgery--15 years after clinical introduction. World J Surg (2006) 1.72

Barrett esophagus: risk factors for progression to dysplasia and adenocarcinoma. Ann Surg (2005) 1.40

Antireflux surgery for dysplastic Barrett. World J Surg (2015) 1.40

Predictors of progression in Barrett's esophagus: current knowledge and future directions. Am J Gastroenterol (2010) 1.35

BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia. Am J Gastroenterol (2015) 1.17

Efficacy of Nissen fundoplication versus medical therapy in the regression of low-grade dysplasia in patients with Barrett esophagus: a prospective study. Ann Surg (2006) 1.12

Clinical and pathologic response of Barrett's esophagus to laparoscopic antireflux surgery. Ann Surg (2003) 1.08

The effect of antireflux surgery on esophageal carcinogenesis in patients with barrett esophagus: a systematic review. Ann Surg (2007) 1.00

Impact of the biliary diversion procedure on carcinogenesis in Barrett's esophagus surgically induced by duodenoesophageal reflux in rats. Ann Surg (2004) 0.93

Optimal management of Barrett's esophagus: pharmacologic, endoscopic, and surgical interventions. Ther Clin Risk Manag (2011) 0.86

Pathophysiology and treatment of Barrett's esophagus. World J Gastroenterol (2010) 0.85

A systematic review and meta-analysis of the treatment for Barrett's esophagus. Dig Dis Sci (2008) 0.85

Complications and frequency of redo antireflux surgery in Denmark: a nationwide study, 1997-2005. Surg Endosc (2007) 0.84

Surgical treatment of Barrett's esophagus: 1980-2003. World J Surg (2004) 0.84

EAES recommendations for the management of gastroesophageal reflux disease. Surg Endosc (2014) 0.84

Histopathology of columnar-lined esophagus in patients with gastroesophageal reflux disease. Wien Klin Wochenschr (2007) 0.83

Endoscopic ablation of Barrett's esophagus using high power setting argon plasma coagulation: a prospective study. World J Gastroenterol (2005) 0.83

Reflux esophagitis, high-grade neoplasia, and early Barrett's carcinoma-what is the place of the Merendino procedure? Langenbecks Arch Surg (2008) 0.83

Laparoscopic Nissen fundoplication in the treatment of Barrett's esophagus - 10 years of experience. Wideochir Inne Tech Maloinwazyjne (2013) 0.83

Barrett's oesophagus: Evidence from the current meta-analyses. World J Gastrointest Pathophysiol (2014) 0.82

Magnitude of Missed Esophageal Adenocarcinoma After Barrett's Esophagus Diagnosis: A Systematic Review and Meta-analysis. Gastroenterology (2015) 0.81

Effect of medical and surgical treatment of Barrett's metaplasia. World J Gastroenterol (2010) 0.80

Multilayered epithelium may be found in patients with Barrett's epithelium and dysplasia or adenocarcinoma. Dig Dis Sci (2006) 0.80

The impact of laparoscopic anti-reflux surgery in patients with Barrett's esophagus. Surg Endosc (2014) 0.80

Management strategies of Barrett's esophagus. World J Gastroenterol (2012) 0.79

A novel esophageal-preserving approach to treat high-grade dysplasia and superficial adenocarcinoma in the presence of chronic gastroesophageal reflux disease. World J Surg (2012) 0.79

Long-term results of ablation with antireflux surgery for Barrett's esophagus: a clinical and molecular biologic study. Surg Endosc (2012) 0.78

The patterns of reflux can affect regression of non-dysplastic and low-grade dysplastic Barrett's esophagus after medical and surgical treatment: a prospective case-control study. Surg Endosc (2014) 0.77

Laparoscopic treatment of Barrett's esophagus: long-term results. Surg Endosc (2006) 0.77

Surveillance in Patients With Barrett's Esophagus for Early Detection of Esophageal Adenocarcinoma: A Systematic Review and Meta-Analysis. Clin Transl Gastroenterol (2015) 0.76

Current Concepts in Treatment of Barrett's Esophagus With and Without Dysplasia. J Gastrointest Surg (2017) 0.75

Barrett's oesophagus: Is there a need for laparoscopic anti-reflux surgery? J Minim Access Surg (2005) 0.75

Barrett's esophagus: where do we stand? Saudi J Gastroenterol (2009) 0.75

Factors predicting outcomes of laparoscopic Nissen fundoplication for gastroesophageal reflux disease: experience at a single institution in Korea. Ann Surg Treat Res (2017) 0.75

Anti-reflux surgery for Barrett's esophagus? Gastroenterology (2004) 0.75

Operable gastro-oesophageal junctional adenocarcinoma: Where to next? World J Gastrointest Oncol (2014) 0.75

Antireflux Surgery in Korea: A Nationwide Study from 2011 to 2014. Gut Liver (2016) 0.75

Barrett's esophagus: now what? Ann Surg (2003) 0.75

Feasibility, safety, and short-term efficacy of the laparoscopic Nissen-Hill hybrid repair. Surg Endosc (2015) 0.75

How should Barrett's ulceration be treated? Surg Endosc (2004) 0.75

From Heartburn to Barrett's Esophagus, and Beyond. World J Surg (2017) 0.75

Review on novel concepts of columnar lined esophagus. Wien Klin Wochenschr (2013) 0.75

Incorporation of Nissen fundoplication in a rat model of duodenoesophageal reflux. Surg Endosc (2006) 0.75

Advances in the Diagnosis and Treatment of Barrett's Esophagus and Early Esophageal Cancer; Summary of the Kelly and Carlos Pellegrini SSAT/SAGES Luncheon Symposium. J Gastrointest Surg (2017) 0.75

Articles cited by this

Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial. JAMA (2001) 8.40

Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol (1983) 8.24

Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa. Gastroenterology (2000) 5.40

Is there publication bias in the reporting of cancer risk in Barrett's esophagus? Gastroenterology (2000) 4.74

Comparison of medical and surgical therapy for complicated gastroesophageal reflux disease in veterans. The Department of Veterans Affairs Gastroesophageal Reflux Disease Study Group. N Engl J Med (1992) 3.50

Role of acid and duodenogastroesophageal reflux in gastroesophageal reflux disease. Gastroenterology (1996) 2.44

Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus. Am J Gastroenterol (1997) 2.43

Conservative treatment versus antireflux surgery in Barrett's oesophagus: long-term results of a prospective study. Br J Surg (1996) 1.99

Successful elimination of reflux symptoms does not insure adequate control of acid reflux in patients with Barrett's esophagus. Am J Gastroenterol (1994) 1.97

Bile reflux in benign and malignant Barrett's esophagus: effect of medical acid suppression and nissen fundoplication. J Gastrointest Surg (1999) 1.69

Personal review: alarmism or legitimate concerns about long-term suppression of gastric acid secretion? Aliment Pharmacol Ther (2000) 1.65

Long-term ambulatory enterogastric reflux monitoring. Validation of a new fiberoptic technique. Dig Dis Sci (1993) 1.56

Long-term outcome of antireflux surgery in patients with Barrett's esophagus. Ann Surg (2001) 1.48

The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus. Am J Gastroenterol (1998) 1.35

Complete elimination of reflux symptoms does not guarantee normalization of intraesophageal acid reflux in patients with Barrett's esophagus. Am J Gastroenterol (1998) 1.18

Long-term results of classic antireflux surgery in 152 patients with Barrett's esophagus: clinical, radiologic, endoscopic, manometric, and acid reflux test analysis before and late after operation. Surgery (1998) 1.16

Effect of omeprazole 20 mg twice daily on duodenogastric and gastro-oesophageal bile reflux in Barrett's oesophagus. Gut (1998) 1.13

Partial regression of Barrett's esophagus by long-term therapy with high-dose omeprazole. Gastrointest Endosc (1996) 1.05

Results of Nissen fundoplication. A cost analysis. Surg Endosc (1995) 0.95

Cost effectiveness of medical versus surgical treatment in patients with severe or refractory gastroesophageal reflux disease in the Netherlands. Scand J Gastroenterol (1996) 0.95

Results of the Collis-Nissen gastroplasty in patients with Barrett's esophagus. Ann Thorac Surg (1999) 0.91

24-h pH monitoring is necessary to assess acid reflux suppression in patients with Barrett's oesophagus undergoing treatment with proton pump inhibitors. Br J Surg (1999) 0.91

Postfundoplication complications. Prevention and management. Gastroenterol Clin North Am (1999) 0.87

Lifetime costs of surgical versus medical treatment of severe gastro-oesophageal reflux disease in Finland. Scand J Gastroenterol (1997) 0.85

Intestinal metaplasia in patients with columnar lined esophagus is associated with high levels of duodenogastroesophageal reflux. Ann Surg (2001) 0.84

Barrett's esophagus: continuing questions and controversy. Gastrointest Endosc (1999) 0.84

Early laparoscopic Nissen fundoplication for recurrent reflux esophagitis: a cost-effective alternative to omeprazole. JSLS (1999) 0.82

Articles by these authors

Open vs laparoscopic repair of spigelian hernia: a prospective randomized trial. Arch Surg (2002) 2.42

Prospective study of postoperative complications after total thyroidectomy for multinodular goiters by surgeons with experience in endocrine surgery. Ann Surg (2004) 1.98

Outpatient laparoscopic incisional/ventral hernioplasty: our experience in 55 cases. Surg Laparosc Endosc Percutan Tech (2002) 1.63

Human thrombin for treatment of pseudoaneurysms: comparison of bovine and human thrombin sonogram-guided injection. AJR Am J Roentgenol (2005) 1.50

Prognostic factors for hepatitis C recurrence in patients undergoing orthotopic liver transplantation. Transpl Immunol (2006) 1.39

Associations of HLA-C alleles with multinodular goiters: study in a population from southeastern Spain. Arch Surg (2006) 1.39

[A comparative study of patients with methicillin susceptible versus methicillin resistant Staphylococcus aureus bacteremia: epidemiology and prognostic factors]. Med Clin (Barc) (2007) 1.39

Positioning trocars for performing sleeve gastrectomy. Points of controversy. Obes Surg (2015) 1.38

Endothelial cell chimerism does not influence allograft tolerance in liver transplant patients after withdrawal of immunosuppression. Transplantation (2003) 1.08

Surgical management of multinodular goiter with compression symptoms. Arch Surg (2005) 1.04

Cytotoxicity and antiproliferative activities of several phenolic compounds against three melanocytes cell lines: relationship between structure and activity. Nutr Cancer (2004) 1.03

Effectiveness of cognitive-behavioral therapy based on the Mediterranean diet for the treatment of obesity. Nutrition (2009) 1.02

Utility of fine-needle aspiration for diagnosis of carcinoma associated with multinodular goitre. Clin Endocrinol (Oxf) (2004) 0.98

Two-dimensional predictive equation to classify visceral obesity in clinical practice. Obesity (Silver Spring) (2006) 0.95

Socio-personal profile of teenagers opposed to organ donation. Nephrol Dial Transplant (2004) 0.95

Surgical treatment for multinodular goitres in geriatric patients. Langenbecks Arch Surg (2005) 0.92

Liver recipients harbouring anti-donor preformed lymphocytotoxic antibodies exhibit a poor allograft survival at the first year after transplantation: experience of one centre. Transpl Immunol (2005) 0.92

Effects of 3 adhesion promoters on the shear bond strength of orthodontic brackets: an in-vitro study. Am J Orthod Dentofacial Orthop (2006) 0.91

Activation of the BMP4 pathway and early expression of CDX2 characterize non-specialized columnar metaplasia in a human model of Barrett's esophagus. J Gastrointest Surg (2011) 0.91

Nosocomial candidemia at a general hospital: the change of epidemiological and clinical characteristics. A comparative study of 2 cohorts (1993-1998 versus 2002-2005). Rev Iberoam Micol (2009) 0.90

A comparison of the shear bond strength of a resin cement and two orthodontic resin adhesive systems. Angle Orthod (2005) 0.89

Biological dosimetry and Bayesian analysis of chromosomal damage in thyroid cancer patients. Radiat Prot Dosimetry (2007) 0.89

Creutzfeldt-Jakob disease acquired via a dural graft: failure of therapy with quinacrine and chlorpromazine. Surg Neurol (2005) 0.88

Age-related changes in fatty acids from different adipose depots in rat and their association with adiposity and insulin. Nutrition (2008) 0.87

Effect on oximetry of dyes used for sentinel lymph node biopsy. Arch Surg (2004) 0.86

Multidrug and carbapenem-resistant Acinetobacter baumannii infections: Factors associated with mortality. Med Clin (Barc) (2011) 0.86

Predictive value of MicroRNAs in the progression of barrett esophagus to adenocarcinoma in a long-term follow-up study. Ann Surg (2013) 0.85

High risk of malignancy in familial Barrett's esophagus: presentation of one family. J Clin Gastroenterol (2008) 0.85

Very long-term objective evaluation of heller myotomy plus posterior partial fundoplication in patients with achalasia of the cardia. Ann Surg (2008) 0.84

Advocacy and resource mobilization for rubella elimination in Guatemala. J Infect Dis (2011) 0.84

In vitro study of force decay of latex and non-latex orthodontic elastics. Eur J Orthod (2011) 0.83

Severe acute lower gastrointestinal bleeding: risk factors for morbidity and mortality. Langenbecks Arch Surg (2006) 0.83

Immediate, early, and late morbidity with laparoscopic ventral hernia repair and tolerance to composite mesh. Surg Laparosc Endosc Percutan Tech (2004) 0.82

Effect of SonoVue on the synovial membrane in rabbit knees. J Ultrasound Med (2011) 0.82

Shear bond strength of orthodontic brackets bonded with self-etching primers. Am J Dent (2005) 0.82

Acute lower gastrointestinal hemorrhages in geriatric patients. Dig Dis Sci (2005) 0.82

[Carbapenem and multidrug-resistant Acinetobacter baumannii colonisation/infection: epidemiology and factors associated with infection]. Med Clin (Barc) (2010) 0.81

Frequency of HLA-C alleles in differentiated thyroid carcinoma in southeastern Spain. Cancer (2004) 0.81

Small bowel adenocarcinoma diagnosed by double balloon enteroscopy in a patient with nonpolyposis colorectal cancer. Rev Esp Enferm Dig (2011) 0.81

Surgical treatment of multinodular goiter in young patients. Endocrine (2005) 0.81

HBV and HCV infections and acute rejection differentially modulate CD95 and CD28 expression on peripheral blood lymphocytes after liver transplantation. Hum Immunol (2006) 0.80

Increased transcutaneous oxygen pressure is an indicator of revascularization after peripheral transluminal angioplasty. Acta Radiol (2010) 0.80

A solution to ankle-brachial index limitations in peripheral transluminal angioplasty. Radiol Med (2013) 0.79

Proliferation and apoptosis of spermatogonia in postpuberal boar (Sus domesticus) testes with spontaneous unilateral and bilateral abdominal cryptorchidism. Acta Histochem (2005) 0.79

Results of surgical treatment in multinodular goiter with an intrathoracic component. Surg Today (2008) 0.79

When is coagulase-negative Staphylococcus bacteraemia clinically significant? Scand J Infect Dis (2013) 0.79

Validation of a nomogram to predict the presence of sentinel lymph node metastases in melanoma. Ann Surg Oncol (2008) 0.77

Nosocomial candidemia at a general hospital: prognostic factors and impact of early empiric treatment on outcome (2002-2005). Med Clin (Barc) (2009) 0.77

Barrett's esophagus without esophageal stricture does not increase the rate of failure of Nissen fundoplication. Ann Surg (2003) 0.77

Proliferation and apoptosis in the seminiferous epithelium of photoinhibited Syrian hamsters (Mesocricetus auratus). Int J Androl (2002) 0.77

Positive progesterone receptors and cell proliferation index: an independent association with breast cancer in males. Breast (2010) 0.77

Experimental model of pulmonary metastasis treatment with IFNalpha. Cancer Lett (2004) 0.77

[Outpatient monitoring of oesophageal pH with a catheter-free pH-meter (Bravo System). A Study of tolerance, safety and efficacy]. Cir Esp (2008) 0.76

Multicenter validation of two nomograms to predict non-sentinel node involvement in breast cancer. Clin Transl Oncol (2012) 0.76

Long-term follow-up of malignancy biomarkers in patients with Barrett's esophagus undergoing medical or surgical treatment. Ann Surg (2012) 0.76

What is the impact of a rapid diagnostic E-test in the treatment of patients with Gram-negative bacteraemia? Scand J Infect Dis (2013) 0.76

Apoptosis and molecular pathways in the seminiferous epithelium of aged and photoinhibited Syrian hamsters (Mesocricetus auratus). J Androl (2006) 0.76

Lack of association between the -403G/A promoter polymorphism in the human CCL5/RANTES chemokine gene in liver transplant outcome. Transpl Int (2006) 0.75

Protein oxidative stress in dialysis patients. Adv Perit Dial (2002) 0.75

[Surgical treatment of high-grade dysplasia in Barrett's esophagus]. Cir Esp (2007) 0.75

[Laparoscopic treatment of achalasia of the cardia. Analysis of results and reflections on the technique]. Cir Esp (2011) 0.75

Multiple lymphatic basin drainage from cutaneous melanoma as a prognostic factor. World J Surg (2012) 0.75

[Study of a cohort of patients with Enterococcus spp. Bacteraemia. Risk factors associated to high-level resistance to aminoglycosides]. Rev Esp Quimioter (2013) 0.75

Standard antireflux operations in patients who have Barrett's esophagus. Current results. Chest Surg Clin N Am (2002) 0.75

Adhesion promoters: effects on the bond strength of brackets. Am J Dent (2005) 0.75

[Multivariate study of risk factors for developing complications after multinodular goiter surgery]. Cir Esp (2005) 0.75

Efficacy of intralesional triamcinolone injection in the treatment of mammillary fistula: a prospective study. Acta Radiol (2013) 0.75

[Acute amoebic appendicitis]. Cir Esp (2012) 0.75

CT60 A/G marker of the 3'-UTR of the CTLA4 gene and liver transplant. Transpl Immunol (2007) 0.75

[Clinical and economic analysis of an internal medicine-infectious disease department at a university general hospital (2005-2006)]. Enferm Infecc Microbiol Clin (2009) 0.75

Endothelial nitric oxide synthase gene polymorphism in dialysis patients. Adv Perit Dial (2002) 0.75

[Brain abscess. The experience of 30 years]. Med Clin (Barc) (2008) 0.75

Desmoplastic nested spindle cell tumor of the liver in an adult. Ann Diagn Pathol (2009) 0.75

Presurgical assessment of the tumor burden of familial medullary thyroid carcinoma by calcitonin testing. J Am Coll Surg (2002) 0.75

Diagnostic efficiency of sestamibi gammagraphy and Doppler sonography in the preoperative assessment of breast lesions. Clin Transl Oncol (2006) 0.75

[Evaluation of the aesthetic results perceived by patients after 3-port laparoscopic appendectomy]. Cir Esp (2011) 0.75

Acute cellular rejection versus recurrent hepatitis C after liver transplantation: Clinical and pathological features driving a rational diagnostic approach. Hepatol Res (2014) 0.75

[Esophageal tuberculosis]. Rev Gastroenterol Peru (2006) 0.75

[Bacteraemia at a second level hospital: epidemiological study, analysis of pronostic factors associated to mortality and economic cost estimation]. Rev Esp Quimioter (2013) 0.75

[Predictive factors of ESBL versus non-ESBL Escherichia coli bacteraemia and influence of resistance on the mortality of the patients]. Med Clin (Barc) (2010) 0.75